Skip to content
Fermenta Biotech logo

Fermenta Biotech

FERMENTA NSE
₹443.85 up 1.10 (0.25%)
Market Cap
₹1,306 Cr
P/E
21.89

Fermenta Biotech (FERMENTA) share price was ₹442.75 at the 28 Oct 2026 close; market capitalisation ₹1,303 Cr; P/E (TTM) 21.83; sector Healthcare. The share price rose 65.6% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 10.6% year on year to ₹121.82 Cr and net profit fell 55.9% year on year to ₹9.53 Cr (compared with Jun 2025). Promoters held 60.12% of Fermenta Biotech in Sep 2026, down 3.97 percentage points from Jun 2026. Its Tapetide Score is 56/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹442.75 +179.90 +68.44% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹1,306 Cr
P/E (TTM)
21.89
EBITDA
₹122 Cr
Return on Equity
17.54%
Debt to Equity
0.28
Book Value
₹138.15
EPS (TTM)
₹20.28
52W High
₹582.65
52W Low
₹248.85

Price-based figures as of 29 Oct 2026, 10:45 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,766.7035.054,23,891 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,655.0087.632,56,310 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,610.5072.381,75,369 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,188.00108.101,18,220 Cr22.310.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.3026.291,17,835 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,364.8032.701,10,257 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Fermenta Biotech (this company)
₹443.8521.891,306 Cr3.210.84%17.54%24.46%538 Cr58 Cr
Median 8 companies₹1,565.7534.861,18,028 Cr4.710.72%14.56%18.45%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

56 Good
Overall score

Data confidence 100/100

insider_selling

Category scores

Quality Good 60
Returns, margins, earnings quality 22% weight
Valuation Strong 80
Cheap vs sector & own history 24% weight
Growth Poor 8
Sales & profit trajectory 9% weight
Financial Health Average 53
Solvency, leverage, coverage 9% weight
Momentum Strong 66
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

4
  • Promoter holding has decreased over last quarter: -3.96%
  • The company has delivered a poor sales growth of 6.85% over past five years.
  • Company has a low return on equity of 12.6% over last 3 years.
  • Working capital days have increased from 48.7 days to 96.2 days

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
10
Neutral
4
Bullish
5

Moving Averages

Bearish

Bearish
8
Neutral
0
Bullish
2

Growth Rate

Revenue Growth
13.82% lower than 3Y

change over 1 year

Net Income Growth
-7.98% lower than 3Y

change over 1 year

Cash Flow Change
127%

change over 1 year

EBITDA Margin Change
-11.71%

change over 1 year Operating margin 14.83% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
82.45
56.91
98.97
97.34
78.13
95.03
156
140
136
130
137
122
122
Expenses
71.52
70.82
73.84
91.96
77.33
76.25
103
103
108
104
112
102
104
Operating Profit
10.93
-13.91
25.13
5.38
0.8
18.78
53.27
36.95
28.24
26.64
24.96
20
18.06
OPM %
13.26%
-24.44%
25.39%
5.53%
1.02%
19.76%
34.04%
26.42%
20.73%
20.46%
18.17%
16.45%
14.83%
Other Income
2.01
-5.53
2.52
5.38
2.82
2.88
2.23
3.89
8.77
5.43
0.92
14.14
4.37
Interest
4.78
3.69
5.19
3.39
3.43
3.69
4.08
2.99
3.11
2.58
3.03
2.82
2.54
Depreciation
5.95
5.93
6.38
6.46
6.12
6.15
6.08
5.86
5.81
5.41
5.37
5.11
5.2
PBT
2.21
-29.06
16.08
0.91
-5.93
11.82
45.34
31.99
28.09
24.08
17.48
26.21
14.69
Tax %
0%
0%
37.81%
884.62%
0%
5.92%
16.43%
-4.19%
23.07%
25.17%
31.24%
29.03%
35.13%
Net Profit
2.21
-29.07
9.99
-7.14
-5.93
11.12
37.89
33.32
21.6
18.03
12.02
18.6
9.53
EPS (₹)
0.62
-9.7
3.35
-2.36
-1.98
3.87
12.54
11.68
7.42
6.14
4.31
6.52
3.31
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
142
155
164
302
403
292
376
397
349
335
468
523
511
Expenses
126
134
152
209
248
225
293
335
330
307
352
422
421
Operating Profit
16
21
12
93
156
66
83
62
18
28
115
101
90
OPM %
11%
13%
7%
31%
39%
23%
22%
16%
5%
8%
25%
19%
18%
Other Income
0
1
3
9
6
12
8
8
-20
4
7
29
25
Interest
4
6
10
14
21
20
19
18
21
17
15
13
11
Depreciation
9
8
10
12
12
15
20
26
28
25
24
22
21
PBT
3
7
-6
76
129
43
52
27
-51
-10
83
96
82
Tax %
67%
61%
49%
28%
8%
-37%
18%
44%
4%
143%
8%
27%
—
Net Profit
1
2
-9
46
117
60
43
15
-53
-24
76
70
58
EPS (₹)
0.17
-0.41
-4.14
12.21
42.71
20.23
15.46
5.25
-17.36
-7.84
26.12
24.39
20.28
Div. Payout %
249%
-51%
-5%
2%
1%
24%
16%
23%
-7%
-16%
9%
15%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
2
2
5
14
14
14
14
14
15
14
Reserves
129
128
142
122
246
295
346
358
301
274
348
392
Borrowings
71
89
87
173
209
224
232
239
220
139
115
113
Other Liabilities
60
70
75
87
92
80
94
96
102
120
137
128
Total Liabilities
262
288
307
385
551
614
687
707
637
548
614
648
Fixed Assets
85
168
172
177
178
200
263
299
267
269
227
220
CWIP
65
6
5
4
22
71
57
35
45
2
16
13
Investments
18
15
18
10
8
0
0
0
3
0
0
0
Other Assets
94
99
112
193
344
342
367
373
321
277
372
414
Total Assets
262
288
307
385
551
614
687
707
637
548
614
648
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
15
4
2
59
90
34
63
43
116
105
41
93
Investing
-18
-13
7
-101
-97
-44
-41
-26
-55
-16
0
-43
Financing
1
10
-12
89
12
-47
-1
-22
-41
-91
-51
-42
Net Cash Flow
-2
1
-4
47
6
-57
21
-4
19
-1
-10
8
Free Cash Flow
-20
-25
-17
42
55
-34
7
6
76
86
38
63
CFO/EBITDA
119
35
35
83
79
73
92
85
610
370
38
108
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
91
101
99
83
59
87
66
80
44
76
74
78
Inventory Days
125
160
208
234
347
594
441
380
309
245
285
290
Days Payable
95
113
147
183
169
260
169
154
109
182
178
147
Cash Conversion Cycle
122
148
160
134
237
421
338
306
244
139
181
221
Working Capital Days
-61
-49
33
54
43
70
54
67
-18
9
40
96
ROCE %
3%
6%
2%
31%
41%
12%
13%
7%
0%
3%
23%
21%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Fermenta Biotech insights

65 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

FIIs1.05%Promot.60.12%Others7.73%Public31.09%As ofSep 2026

Documents

1
Concall - Aug 2026 Aug 2026
2
Concall - May 2026 May 2026
3
Concall - Feb 2026 Feb 2026
4
Concall - Nov 2025 Nov 2025
5
Concall - Aug 2025 Aug 2025

Frequently Asked Questions about Fermenta Biotech

What does Fermenta Biotech Ltd do?
Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]
Where is Fermenta Biotech Ltd (FERMENTA) listed?
Fermenta Biotech Ltd trades as FERMENTA on the NSE and under code 506414 on the BSE.
Which sector does Fermenta Biotech Ltd belong to?
Fermenta Biotech Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Fermenta Biotech Ltd?
Fermenta Biotech Ltd has a market capitalisation of ₹1,306 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Fermenta Biotech Ltd?
Fermenta Biotech Ltd trades at a PE ratio of 21.89 as of 29 Oct 2026, on earnings per share of ₹20.28, against a book value of ₹138.15 per share.
What is the 52-week high and low of Fermenta Biotech Ltd?
Over the last 52 weeks Fermenta Biotech Ltd has traded between ₹248.85 and ₹582.65 as of 29 Oct 2026.
Does Fermenta Biotech Ltd pay dividends?
Fermenta Biotech Ltd has a dividend yield of 0.85%.
What is the Return on Equity (ROE) of Fermenta Biotech Ltd?
Fermenta Biotech Ltd reported a return on equity of 17.54%. Its debt-to-equity ratio is 0.28.

Company Information

Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

Website dil.net
CEO Mr. Prashant Prabhakar Nagre
Employees 606
Listed 2026-08-04
Face Value ₹ 5
Shares Outstanding 2,94,30,987

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506414.md for Fermenta Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month